Dr. John Bell
Dr. John Bell received his PhD from McMaster University in 1982. In the three years that followed, he trained as a post-doctoral fellow at the University of Ottawa and then at the Medical Research Council in London, England. Dr. Bell began his independent research career at McGill University in 1986 and moved to the University of Ottawa, Department of Medicine, in 1989. He is a member of the Center for Cancer Therapeutics at The Ottawa Hospital Cancer Center, a Senior Scientist with the Ottawa Hospital Research Institute and Professor of Medicine at the University of Ottawa. He is currently the Scientific Director of BioCanRx, a Network of Centres of Excellence that aims to bring novel immune stimulating therapies to cancer patients across Canada. Dr. Bell is a Fellow of the Royal Society of Canada. New Approaches for Treating Cancer
Dr. John Bell received his PhD from McMaster University in 1982. In the three years that followed, he trained as a post-doctoral fellow at the University of Ottawa and then at the Medical Research Council in London, England. Dr. Bell began his independent research career at McGill University in 1986 and moved to the University of Ottawa, Department of Medicine, in 1989. He is a member of the Center for Cancer Therapeutics at The Ottawa Hospital Cancer Center, a Senior Scientist with the Ottawa Hospital Research Institute and Professor of Medicine at the University of Ottawa. He is currently the Scientific Director of BioCanRx, a Network of Centres of Excellence that aims to bring novel immune stimulating therapies to cancer patients across Canada. Dr. Bell is a Fellow of the Royal Society of Canada.
New Approaches for Treating Cancer
The treatment of cancer to date has largely been dominated by the use of chemotherapy and radiation therapy. While these two approaches have benefited a large number of people, there are many cancer patients whose cancers do not respond and thus they don’t achieve the long-term cures that they hope for. Another emerging therapeutic approach is to use “biologically based” strategies often aimed at stimulating the patient’s own immune system to recognize the cancer as a foreign entity and eliminate it. If successful, these therapies have the benefit of eliminating the tumor and providing “immunological memory” to keep the cancer from returning. In my presentation I will discuss some of these novel approaches and how the field of cancer therapy is evolving. This event is part of the Fall 2020 Speaker series.
The treatment of cancer to date has largely been dominated by the use of chemotherapy and radiation therapy. While these two approaches have benefited a large number of people, there are many cancer patients whose cancers do not respond and thus they don’t achieve the long-term cures that they hope for. Another emerging therapeutic approach is to use “biologically based” strategies often aimed at stimulating the patient’s own immune system to recognize the cancer as a foreign entity and eliminate it. If successful, these therapies have the benefit of eliminating the tumor and providing “immunological memory” to keep the cancer from returning. In my presentation I will discuss some of these novel approaches and how the field of cancer therapy is evolving.
This event is part of the Fall 2020 Speaker series.
Founding Members
Governance & Compliance - Bylaws
Speaker Events
7 Great Reasons to Join
.JPG)
